Literature DB >> 8408390

Analysis of 6R- and 6S-tetrahydrobiopterin and other pterins by reversed-phase ion-pair liquid-chromatography with fluorimetric detection by post-column sodium nitrite oxidation.

Y Tani1, T Ohno.   

Abstract

A rapid and sensitive reversed-phase ion-pair liquid chromatographic system with fluorimetric detection by post-column sodium nitrite oxidation was established for measuring six pterin compounds (6R-5,6,7,8-tetrahydrobiopterin, 6S,5,6,7,8-tetrahydrobiopterin, 7,8-dihydrobiopterin, biopterin, pterin and D-neopterin). The coefficients of variation for these pterins were 0.705-3.714%, and the minimum detectable amount was ca. 10-20 pg at a signal-to-noise ratio of 3. A linear detector response was also verified. The concentrations of the pterin compounds in rat tissues were measured by the described method. Furthermore, by means of brain microdialysis, the output of pterin compounds from rat striatum was detected. Therefore, these results demonstrate that this system can be applied to analyses not only of various rat tissues but also of dialysates collected in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408390     DOI: 10.1016/0378-4347(93)80495-p

Source DB:  PubMed          Journal:  J Chromatogr


  8 in total

1.  Reversible S-glutathionylation of human 6-pyruvoyl tetrahydropterin synthase protects its enzymatic activity.

Authors:  Satoshi Hara; Soichiro Fukumura; Hiroshi Ichinose
Journal:  J Biol Chem       Date:  2018-12-04       Impact factor: 5.157

2.  Simultaneous determination of all forms of biopterin and neopterin in cerebrospinal fluid.

Authors:  Pierre Guibal; Nathalie Lévêque; Diane Doummar; Nicolas Giraud; Emmanuel Roze; Diana Rodriguez; Rémy Couderc; Thierry Billette De Villemeur; Fathi Moussa
Journal:  ACS Chem Neurosci       Date:  2014-04-08       Impact factor: 4.418

3.  Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson's disease.

Authors:  Hiroshi Ichinose; Ken-Ichi Inoue; Shinobu Arakawa; Yuki Watanabe; Hiroki Kurosaki; Shoko Koshiba; Eldbjorg Hustad; Masahiko Takada; Jan O Aasly
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

4.  Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice.

Authors:  H Miura; H Qiao; T Kitagami; T Ohta; N Ozaki
Journal:  Psychopharmacology (Berl)       Date:  2004-07-29       Impact factor: 4.530

5.  Sepiapterin reductase gene-disrupted mice suffer from hypertension with fluctuation and bradycardia.

Authors:  Chiho Sumi-Ichinose; Yui Suganuma; Taiki Kano; Noriko Ihira; Hiroko Nomura; Kazuhisa Ikemoto; Tadayoshi Hata; Setsuko Katoh; Hiroshi Ichinose; Kazunao Kondo
Journal:  Physiol Rep       Date:  2017-03

6.  Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders.

Authors:  Taizo Ishikawa; Keiko Imamura; Takayuki Kondo; Yasushi Koshiba; Satoshi Hara; Hiroshi Ichinose; Mahoko Furujo; Masako Kinoshita; Tomoko Oeda; Jun Takahashi; Ryosuke Takahashi; Haruhisa Inoue
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

7.  Single-Step Rapid Diagnosis of Dopamine and Serotonin Metabolism Disorders.

Authors:  Aurélien Lo; Pierre Guibal; Diane Doummar; Diana Rodriguez; Jean-Yves Hautem; Rémy Couderc; Thierry Billette De Villemeur; Emmanuel Roze; Pierre Chaminade; Fathi Moussa
Journal:  ACS Omega       Date:  2017-09-19

8.  Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathy.

Authors:  Kengo Kidokoro; Minoru Satoh; Keith M Channon; Toyotaka Yada; Tamaki Sasaki; Naoki Kashihara
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.